JP6714278B2 - 基質抗原同時検出バイオセンサ、基質抗原同時検出方法、および、プログラム - Google Patents
基質抗原同時検出バイオセンサ、基質抗原同時検出方法、および、プログラム Download PDFInfo
- Publication number
- JP6714278B2 JP6714278B2 JP2016548838A JP2016548838A JP6714278B2 JP 6714278 B2 JP6714278 B2 JP 6714278B2 JP 2016548838 A JP2016548838 A JP 2016548838A JP 2016548838 A JP2016548838 A JP 2016548838A JP 6714278 B2 JP6714278 B2 JP 6714278B2
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- substrate
- biosensor
- current value
- change
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims description 107
- 239000000427 antigen Substances 0.000 title claims description 95
- 102000036639 antigens Human genes 0.000 title claims description 84
- 108091007433 antigens Proteins 0.000 title claims description 84
- 239000000758 substrate Substances 0.000 title claims description 70
- 230000008859 change Effects 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 48
- 238000004458 analytical method Methods 0.000 claims description 30
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims description 27
- 108090000790 Enzymes Proteins 0.000 claims description 24
- 102000004190 Enzymes Human genes 0.000 claims description 24
- 229940088598 enzyme Drugs 0.000 claims description 24
- 239000004366 Glucose oxidase Substances 0.000 claims description 20
- 229940116332 glucose oxidase Drugs 0.000 claims description 20
- 235000019420 glucose oxidase Nutrition 0.000 claims description 20
- 108010015776 Glucose oxidase Proteins 0.000 claims description 19
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 238000006911 enzymatic reaction Methods 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 15
- 210000001124 body fluid Anatomy 0.000 claims description 14
- 239000010839 body fluid Substances 0.000 claims description 14
- 238000002848 electrochemical method Methods 0.000 claims description 13
- 102000009027 Albumins Human genes 0.000 claims description 11
- 108010088751 Albumins Proteins 0.000 claims description 11
- 210000002700 urine Anatomy 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 8
- 239000013060 biological fluid Substances 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 108010077078 Creatinase Proteins 0.000 claims description 5
- 239000007857 degradation product Substances 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims 8
- 230000001678 irradiating effect Effects 0.000 claims 3
- 229920001940 conductive polymer Polymers 0.000 description 59
- 239000008103 glucose Substances 0.000 description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 23
- 239000010409 thin film Substances 0.000 description 17
- 238000010586 diagram Methods 0.000 description 14
- 238000004891 communication Methods 0.000 description 13
- 230000003287 optical effect Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 230000008569 process Effects 0.000 description 12
- 238000012545 processing Methods 0.000 description 12
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 239000002953 phosphate buffered saline Substances 0.000 description 11
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 10
- 229910052737 gold Inorganic materials 0.000 description 10
- 239000010931 gold Substances 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 238000003860 storage Methods 0.000 description 10
- 239000011521 glass Substances 0.000 description 9
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000000835 electrochemical detection Methods 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 229940109239 creatinine Drugs 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000888 electrochemical surface plasmon resonance spectroscopy Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000128 polypyrrole Polymers 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- 0 C(*1)*11CCCC1 Chemical compound C(*1)*11CCCC1 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- GTKRFUAGOKINCA-UHFFFAOYSA-M chlorosilver;silver Chemical compound [Ag].[Ag]Cl GTKRFUAGOKINCA-UHFFFAOYSA-M 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002484 cyclic voltammetry Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000036046 immunoreaction Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/41—Refractivity; Phase-affecting properties, e.g. optical path length
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Electrochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Sustainable Development (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Description
以下、本発明の実施の形態の概要について図1を参照して説明し、その後、本実施形態の構成および処理等について詳細に説明する。図1は、本実施形態の基本原理を示すフローチャートである。本実施形態は、概略的に、以下の基本的特徴を有する。
次に、本実施形態における基質抗原同時検出バイオセンサ100の構成の詳細について、図2および図3を参照して以下に説明する。図2は、本実施形態における基質抗原同時検出バイオセンサ100の構成の一例を示すブロック図であり、該構成のうち本発明に関係する部分のみを概念的に示している。
次に、このように構成された本実施形態における基質抗原同時検出バイオセンサ100の処理の詳細について、以下に図4乃至図9を参照して詳細に説明する。図4は、本実施形態における基質抗原同時検出バイオセンサ100の処理の一例を示すフローチャートである。
さて、これまで本発明の実施の形態について説明したが、本発明は、上述した実施の形態以外にも、特許請求の範囲に記載した技術的思想の範囲内において種々の異なる実施の形態にて実施されてよいものである。
10 基板
20 作用電極
21 導電性高分子
22 酵素
23 抗体
30 ポテンショスタット
31 対電極
32 参照電極
40 溶液槽
50 ガラスプリズム
51 レーザ発振器
52 偏光子
53 ディテクタ
100 基質抗原同時検出バイオセンサ
102 制御部
102a 電流値検出部
102b 反射率検出部
102c 解析部
102d 解析結果出力部
106 記憶部
112 入出力部
Claims (10)
- 酵素および抗体が固定されたポリピロールカルボン酸の膜を堆積させた作用電極と、
前記膜における酵素反応に基づく、前記膜上での電流値の変化を検出する電流値検出手段と、
光源から前記作用電極への偏光子を介した光の照射による表面プラズモン共鳴法を用いて、前記膜における抗原抗体反応に基づく、前記作用電極により反射される光の反射率の変化を検出する反射率検出手段と、
を備えたことを特徴とする、基質抗原同時検出バイオセンサ。 - 前記ポリピロールカルボン酸に接する液体を満たした溶液漕、
を更に備えたことを特徴とする、請求項1に記載の基質抗原同時検出バイオセンサ。 - 前記液体は、
体液を含むことを特徴とする、請求項2に記載の基質抗原同時検出バイオセンサ。 - 前記体液は、
尿、生体液、または、血液であることを特徴とする、請求項3に記載の基質抗原同時検出バイオセンサ。 - 前記酵素は、
グルコースオキシダーゼ、または、クレアチナーゼであることを特徴とする、請求項1乃至4のいずれか一つに記載の基質抗原同時検出バイオセンサ。 - 抗原は、
アルブミン、前記アルブミン以外のタンパク質、または、タンパク質の分解産物であるペプチドであることを特徴とする、請求項1乃至5のいずれか一つに記載の基質抗原同時検出バイオセンサ。 - 前記電流値検出手段は、
電気化学測定法を用いて、前記膜における前記酵素反応に基づく、前記膜上での前記電流値の変化を検出することを特徴とする、請求項1乃至6のいずれか一つに記載の基質抗原同時検出バイオセンサ。 - 前記電流値の変化、および、前記反射率の変化に基づく解析結果を取得する解析手段と、
前記解析結果を出力させる解析結果出力手段と、
を更に備えたことを特徴とする、請求項1乃至7のいずれか一つに記載の基質抗原同時検出バイオセンサ。 - 基質抗原同時検出バイオセンサにおいて実行される基質抗原同時検出方法であって、
酵素および抗体が固定されたポリピロールカルボン酸の膜を堆積させた作用電極上の前記膜における酵素反応に基づく、前記膜上での電流値の変化を検出する電流値検出ステップと、
光源から前記作用電極への偏光子を介した光の照射による表面プラズモン共鳴法を用いて、前記膜における抗原抗体反応に基づく、前記作用電極により反射される光の反射率の変化を検出する反射率検出ステップと、
を含むことを特徴とする、基質抗原同時検出方法。 - 基質抗原同時検出バイオセンサに実行させるためのプログラムであって、
酵素および抗体が固定されたポリピロールカルボン酸の膜を堆積させた作用電極上の前記膜における酵素反応に基づく、前記膜上での電流値の変化を検出する電流値検出ステップと、
光源から前記作用電極への偏光子を介した光の照射による表面プラズモン共鳴法を用いて、前記膜における抗原抗体反応に基づく、前記作用電極により反射される光の反射率の変化を検出する反射率検出ステップと、
を実行させるためのプログラム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014191697 | 2014-09-19 | ||
JP2014191697 | 2014-09-19 | ||
PCT/JP2015/075310 WO2016043078A1 (ja) | 2014-09-19 | 2015-09-07 | 基質抗原同時検出バイオセンサ、電極、基質抗原同時検出方法、および、プログラム |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2016043078A1 JPWO2016043078A1 (ja) | 2017-08-31 |
JP6714278B2 true JP6714278B2 (ja) | 2020-06-24 |
Family
ID=55533117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016548838A Active JP6714278B2 (ja) | 2014-09-19 | 2015-09-07 | 基質抗原同時検出バイオセンサ、基質抗原同時検出方法、および、プログラム |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6714278B2 (ja) |
WO (1) | WO2016043078A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3103732A1 (en) * | 2018-07-13 | 2020-01-16 | Aegirbio Ab | Biosensor for diagnosis of thyroid dysfunction |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989011649A1 (en) * | 1988-05-16 | 1989-11-30 | Wollongong Uniadvice Limited | Antibody containing electrode |
JPH02110363A (ja) * | 1988-10-20 | 1990-04-23 | Teijin Ltd | 免疫センサ用動作電極およびその製造方法 |
GB9622304D0 (en) * | 1996-10-26 | 1996-12-18 | Univ Manchester | Sensor |
RU2161653C2 (ru) * | 1998-08-24 | 2001-01-10 | ФАРМАКОВСКИЙ Дмитрий Александрович | Способ количественного электрохимического анализа биомолекул |
WO2000031750A1 (en) * | 1998-11-19 | 2000-06-02 | Bio Merieux | Electrically conductive electroactive functionalized conjugated polymers, and uses thereof |
FR2787582B1 (fr) * | 1998-12-16 | 2001-01-12 | Commissariat Energie Atomique | Procede de fabrication d'une biopuce et biopuce |
JP2001194298A (ja) * | 1999-10-28 | 2001-07-19 | Nippon Telegr & Teleph Corp <Ntt> | 表面プラズモン共鳴酵素センサーおよび表面プラズモン共鳴の測定方法 |
JP2001242072A (ja) * | 2000-03-02 | 2001-09-07 | Kanagawa Acad Of Sci & Technol | 光吸収応答型sprセンサーおよびその測定方法と装置 |
FR2847581B1 (fr) * | 2002-11-21 | 2007-03-23 | Commissariat Energie Atomique | Procede de fixation d'une proteine sur un polymere a base de pyrrole et son utilisation pour la fabrication d'un capteur |
EP1816479A4 (en) * | 2004-11-25 | 2009-01-21 | Panasonic Corp | SENSOR |
JP5424229B2 (ja) * | 2007-09-28 | 2014-02-26 | 独立行政法人産業技術総合研究所 | 酸化膜を用いた光導波モードセンサー及びその製造方法 |
JP5464398B2 (ja) * | 2008-07-17 | 2014-04-09 | 独立行政法人産業技術総合研究所 | フローセルを用いた測定方法 |
JP5487150B2 (ja) * | 2011-03-31 | 2014-05-07 | 富士フイルム株式会社 | 光学的測定方法および光学的測定装置 |
-
2015
- 2015-09-07 JP JP2016548838A patent/JP6714278B2/ja active Active
- 2015-09-07 WO PCT/JP2015/075310 patent/WO2016043078A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JPWO2016043078A1 (ja) | 2017-08-31 |
WO2016043078A1 (ja) | 2016-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Park et al. | Selective electrochemical sensing of glycated hemoglobin (HbA1c) on thiophene-3-boronic acid self-assembled monolayer covered gold electrodes | |
Urmann et al. | Label-free optical biosensors based on aptamer-functionalized porous silicon scaffolds | |
Luo et al. | Ultrasensitive label free electrical detection of insulin in neat blood serum | |
Masson et al. | Quantitative measurement of cardiac markers in undiluted serum | |
Garrote et al. | Perspectives on and precautions for the uses of electric spectroscopic methods in label-free biosensing applications | |
Mariani et al. | Femtomole detection of proteins using a label-free nanostructured porous silicon interferometer for perspective ultrasensitive biosensing | |
Upasham et al. | Development of ultra-low volume, multi-bio fluid, cortisol sensing platform | |
Upasham et al. | Cardiac troponin biosensors: where are we now? | |
Kharitonov et al. | The use of impedance spectroscopy for the characterization of protein-modified ISFET devices: application of the method for the analysis of biorecognition processes | |
Kerman et al. | Label-free electrochemical immunoassay for the detection of human chorionic gonadotropin hormone | |
JP6543346B2 (ja) | 量子キャパシタンス感知 | |
JP5855246B2 (ja) | 校正不要分析による活性濃度の決定方法 | |
Kitade et al. | Potentiometric immunosensor using artificial antibody based on molecularly imprinted polymers | |
Brusatori et al. | Biosensing under an applied voltage using optical waveguide lightmode spectroscopy | |
Patil et al. | Immittance electroanalysis in diagnostics | |
Balahura et al. | Advances in immunosensors for clinical applications | |
Zhang et al. | High-sensitivity glycated hemoglobin (HbA1c) aptasensor in rapid-prototyping surface plasmon resonance | |
Davis et al. | Peptide aptamers in label-free protein detection: 1. Characterization of the immobilized scaffold | |
Zhang et al. | Optical fiber SPR biosensor with a solid-phase enzymatic reaction device for glucose detection | |
Chaplin | Biosensors | |
Bhasin et al. | Virus bioresistor (VBR) for Detection of bladder cancer marker DJ-1 in urine at 10 pM in one minute | |
Karaboğa et al. | Determination of C-reactive protein by PAMAM decorated ITO based disposable biosensing system: A new immunosensor design from an old molecule | |
Bohli et al. | Electrochemical impedance spectroscopy on interdigitated gold microelectrodes for glycosylated human serum albumin characterization | |
Selimoğlu et al. | Silver nanoparticle doped graphene-based impedimetric biosensor towards sensitive detection of procalcitonin | |
Noushin et al. | WRRIST: A wearable, rapid, and real-time infection screening tool for dual-mode detection of inflammatory biomarkers in sweat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20170530 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170609 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180903 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191008 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191205 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200204 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200330 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200507 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200522 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6714278 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |